Want to be grateful? Remember to remember.

“Choose [your memories] carefully. Memories are all we end up with … You’ll have a thousand pasts and no future.” –The Secret Behind Their Eyes (film) Robert Emmons summarizes research on gratitude and reviews the impact of it at a social level. He closes with thoughts on cultivating it at an individual level. Gratitude, at least … Continue reading Want to be grateful? Remember to remember.

Why is talk therapy going out of favor?

A special issue of Clinical Psychology Review examines the decline of talk therapies: Psychotherapy has issues. Evidence shows that some psychosocial treatments work well for common mental health problems such as anxiety and depression and that consumers often prefer them to medication. Yet the use of psychotherapy is on a clear decline in the United States. In a set of research review … Continue reading Why is talk therapy going out of favor?

2012′s most popular posts #8 – Another Reaction to Hazelden’s Adoption of Suboxone

Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading 2012′s most popular posts #8 – Another Reaction to Hazelden’s Adoption of Suboxone

Another Reaction to Hazelden’s Adoption of Suboxone

Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading Another Reaction to Hazelden’s Adoption of Suboxone

We’re not alone

Pat Deegan linked to a report on the state of treatment for schizophrenia for medicaid recipients. Although there was some state-to-state variation in the findings, the study found that, while more than 90 percent of beneficiaries with schizophrenia or bipolar disorder received an evidence-based medication during the year, only 61 percent of those beneficiaries continuously … Continue reading We’re not alone